Nuclear,Medicine,Therapeutics, marketing Nuclear Medicine Therapeutics to boost the Nuclear Medicine
Awhile ago, I got an email from one of the "gurus" I follow and it shocked me. The gist of it was this person wanted to trade services for a household item.To say it floored me would be an understatement.What was worse was a few days later t Automation technologies represent a fundamental aspect of any modern industry. The major types of industrial automation solutions, such as DCS, PLC, SCADA, and MES, are used on a large-scale in process and discrete industries.DCS technologie
The Nuclear medicine market can be segmented into four categories namely on the basis of diagnostic technique, therapeutics mode and on the basis of application and on the basis of geography. The therapeutics market of the nuclear medicine market involves the use of Alpha emitters, Beta emitters and the process of Brachytherapy.Over the past decade, there has been a progressively stronger interest in the use of alpha particle emitters for radio immunotherapy. With proper localization of the labeled antibody, the high linear energy transfer of α-particles provides a correspondingly high probability of mitotic cell kill when compared with an equivalent number of cellular traversals by lower linear energy transfer β-particles. Though this process has great potential, it is yet in the developmental stages and is to be introduced into the market. From the market point of view, this is considered to be a market of great potential filled with huge prospects and expectations. The alpha emitters can be segmented on the basis of the type of alpha emitter.These segments are Radium 223, Actinium 225, Lead 212, Astatine 211, Radium 224 and Thorium 227. Presently the market is at developmental stage and hence the market size is negligible.Beta emitters market is a relatively big market with good growth on a global basis. The beta emitters market can be segmented on the basis of the type of beta emitter used. The types are Iodine 131, Ytrrium-90, Samarium-153, Rhenium-186, Lutetium-177 and other relatively unknown beta emitters. Among the beta emitters Iodine 131 has the major market share followed by others.The other segment in this category is Brachytherapy. It is a form of radiotherapy where a radiation source is placed inside or next to the area requiring treatment. Brachytherapy is commonly used as an effective treatment for cervical, prostate, breast, and skin cancer and can also be used to treat tumors in many other body sites. The Brachytherapy market can be segmented on the type of radiation sources used in the process. The radiation sources used are Cesium 131, Iodine 125, Palladium 103 and Iridium 192. The clinical applications of this market are in the fields of cervical cancer, Prostate cancer, Breast cancer, Skin cancer and Coronary/Vascular cancers. Article Tags: Nuclear Medicine Market, Nuclear Medicine, Medicine Market, Beta Emitters
Nuclear,Medicine,Therapeutics,